Cargando…

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

BACKGROUND: No-reflow is an important factor as it predicts a poor outcome in patients undergoing primary angioplasty. In comparison with patients attaining TIMI 3 flow, patients with no-reflow have an increased incidence of ventricular arrhythmias, early congestive cardiac failure, cardiac rupture...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Jabari, Ali Mohammed Kareem, Elserafy, Ahmed Shawky, Abuemara, Hossamaldin Zaki Alsayed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Egyptian Society of Cardiology 2017
Materias:	Acute Coronary Syndrome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883489/ https://www.ncbi.nlm.nih.gov/pubmed/29622973 http://dx.doi.org/10.1016/j.ehj.2017.01.001

Ejemplares similares

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes
por: Elghawaby, Helmy Hassan, et al.
Publicado: (2018)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Pre-hospital and hospital delay in patients with non-ST elevation acute coronary syndromes in tertiary care
por: Youssef, G.S., et al.
Publicado: (2017)

Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials
por: Hoedemaker, Niels PG, et al.
Publicado: (2019)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
por: Wei, L, et al.
Publicado: (2008)

Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
por: De Luca, G, et al.
Publicado: (2008)

Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations
por: Tamita, Koichi, et al.
Publicado: (2012)

Long-term prognostic value of mitral regurgitation in acute coronary syndromes
por: Persson, Anita, et al.
Publicado: (2010)

The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome
por: Ang, Donald S C, et al.
Publicado: (2012)

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study
por: Padfield, Gareth J, et al.
Publicado: (2013)

Strategic target temperature management in myocardial infarction—a feasibility trial
por: Testori, Christoph, et al.
Publicado: (2013)

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor
por: Parodi, Guido, et al.
Publicado: (2015)

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

Patients with non-obstructive coronary artery disease admitted with acute myocardial infarction carry a better outcome compared to those with obstructive coronary artery disease
por: Abdelmonem, Yasser Yazied, et al.
Publicado: (2017)

Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?
por: Wahab, Mohamed Abdel Kader Abdel
Publicado: (2017)

Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach()()
por: Sultan, El-Zahraa M., et al.
Publicado: (2018)

Risk factors for acute coronary syndrome in patients below the age of 40 years
por: Mirza, Aram J., et al.
Publicado: (2018)

Intravascular evaluation of coronary atherosclerotic lesions among Egyptian diabetic patients with acute coronary syndromes
por: Laimoud, Mohamed, et al.
Publicado: (2018)

Novel Aspects of Classification, Prognosis and Therapy in Takotsubo Syndrome
por: Di Filippo, Chiara, et al.
Publicado: (2019)

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease
por: Banerjee, Debasish, et al.
Publicado: (2019)

Clinical role of serum Copeptin in acute coronary syndrome
por: Abd El Baky Mahmoud, Manal, et al.
Publicado: (2018)

Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score
por: Morttada, Ayman, et al.
Publicado: (2018)

Death anxiety in patients with myocardial infarction or cancer
por: Şahan, Ebru, et al.
Publicado: (2018)

Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
por: Sobhy, Mohamed, et al.
Publicado: (2018)

LB-3 | Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19
por: Quesada, Odayme, et al.
Publicado: (2022)

Sex Differences in Patient-Reported Outcomes in the Immediate Recovery Period After Resuscitation: Findings From the Cross-sectional DenHeart Survey
por: Wagner, Mette Kirstine, et al.
Publicado: (2023)

The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome
por: Li, Wentao, et al.
Publicado: (2023)

No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case–control study (NORM PPCI)
por: Rossington, Jennifer Ann, et al.
Publicado: (2020)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry
por: Dehghani, Payam, et al.
Publicado: (2023)

Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis
por: Walters, Daniel, et al.
Publicado: (2021)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial
por: Fabris, Enrico, et al.
Publicado: (2020)

Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction
por: Banning, Amerjeet S., et al.
Publicado: (2015)

Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic
por: Medranda, Giorgio A., et al.
Publicado: (2021)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020)

Diagnostic Angiograms and Percutaneous Coronary Interventions in Pregnancy
por: Khaing, Phyo Htet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lop5bmuacp08hbr40p8tltc43q